• Explore /
  • Poster
  • / Clinical significance of enterocyte-specific gene polymorphisms as candidate marker of oxaliplatin-based treatment for metastatic colorectal cancer.

Clinical significance of enterocyte-specific gene polymorphisms as candidate marker of oxaliplatin-based treatment for metastatic colorectal cancer.

Abstract Poster

Authors

null

Mitsukuni Suenaga

USC Keck School of Medicine Norris Comprehensive Cancer Center, Los Angeles, CA

Mitsukuni Suenaga , Marta Schirripa , Fotios Loupakis , Shu Cao , Wu Zhang , Chiara Cremolini , Sara Lonardi , Satoshi Okazaki , Martin D. Berger , Yuji Miyamoto , Shivani Soni , Afsaneh Barzi , Toshiharu Yamaguchi , Alfredo Falcone , Heinz-Josef Lenz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Tumor Biology

Track

Tumor Biology

Sub Track

Molecular Diagnostics and Imaging

Citation

J Clin Oncol 36, 2018 (suppl; abstr 12066)

DOI

10.1200/JCO.2018.36.15_suppl.12066

Abstract #

12066

Poster Bd #

179

Abstract Disclosures

Similar Posters

First Author: Dominik Paul Modest

First Author: Kohei Shitara

First Author: Federico Innocenti

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Myostatin/activin pathway gene expression and single nucleotide polymorphisms (SNPs) in metastatic colorectal cancer (mCRC).

Myostatin/activin pathway gene expression and single nucleotide polymorphisms (SNPs) in metastatic colorectal cancer (mCRC).

First Author: Karam Ashouri